Recent

% | $
Quotes you view appear here for quick access.

NewLink Genetics Corporation (NLNK) Message Board

  • acolonf5 acolonf5 Oct 3, 2012 12:29 PM Flag

    Phase 3 Lung Cancer Trial

    It looks like they're going for a somewhat smaller patient profile so that they can be assured of statistically significant results. I believe it's a good decision because they can always try to expand their indication in the future after this trial is a success. Going for a sure single instead of a chance at a home run is very smart. In this case the single could result in a much higher market cap, albeit 4 or 5 years down the line.

    Sentiment: Strong Buy

 
NLNK
42.57-0.79(-1.82%)12:54 PMEDT